Your browser doesn't support javascript.
loading
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus Erythematosus: An International Multicenter Retrospective Study.
Bortoluzzi, Alessandra; Fanouriakis, Antonis; Silvagni, Ettore; Appenzeller, Simone; Carli, Linda; Carrara, Greta; Cauli, Alberto; Conti, Fabrizio; Costallat, Lilian Teresa Lavras; De Marchi, Ginevra; Doria, Andrea; Fredi, Micaela; Franceschini, Franco; Garaffoni, Carlo; Hanly, John G; Mosca, Marta; Murphy, Elana; Piga, Matteo; Quartuccio, Luca; Scirè, Carlo Alberto; Tomietto, Paola; Truglia, Simona; Zanetti, Anna; Zen, Margherita; Bertsias, George; Govoni, Marcello.
Afiliação
  • Bortoluzzi A; Rheumatology Unit, Department of Medical Sciences, Università degli Studi di Ferrara, Azienda Ospedaliero-Universitaria S. Anna, Cona, 44124, Italy.
  • Fanouriakis A; Rheumatology and Clinical Immunology Unit, "Attikon" University Hospital and National Kapodistrian University of Athens Medical School, Athens, 12462, Greece.
  • Silvagni E; Rheumatology Unit, Department of Medical Sciences, Università degli Studi di Ferrara, Azienda Ospedaliero-Universitaria S. Anna, Cona, 44124, Italy.
  • Appenzeller S; Rheumatology Unit, Department of Orthopedics, Rheumatology and Traumatology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, 13083-970, Brazil.
  • Carli L; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, 56124, Italy.
  • Carrara G; Epidemiology Unit, Italian Society of Rheumatology, Milan, 20121, Italy.
  • Cauli A; Rheumatology Unit, University Clinic, AOU Cagliari, 09124, Cagliari, Italy.
  • Conti F; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, 09124, Italy.
  • Costallat LTL; Rheumatology Unit, University of Udine, Department of Medicine, University Hospital Santa Maria della Misericordia, 33100, Udine, Italy.
  • De Marchi G; Rheumatology Unit, Department of Orthopedics, Rheumatology and Traumatology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, 13083-970, Brazil.
  • Doria A; Rheumatology Unit, University of Udine, Department of Medicine, University Hospital Santa Maria della Misericordia, 33100, Udine, Italy.
  • Fredi M; Rheumatology Unit, Department of Medicine-DIMED, University of Padova, Padova, 35128, Italy, Via Giustiniani, 2.
  • Franceschini F; Rheumatology and Clinical Immunology Unit and Clinical and Experimental Science Department ASST Spedali Civili, University of Brescia, Brescia, 25123, Italyand.
  • Garaffoni C; Rheumatology and Clinical Immunology Unit and Clinical and Experimental Science Department ASST Spedali Civili, University of Brescia, Brescia, 25123, Italyand.
  • Hanly JG; Rheumatology Unit, Department of Medical Sciences, Università degli Studi di Ferrara, Azienda Ospedaliero-Universitaria S. Anna, Cona, 44124, Italy.
  • Mosca M; Division of Rheumatology, Departments of Medicine and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center, B3H 4K4, Canada, Halifax, Nova Scotia.
  • Murphy E; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, 56124, Italy.
  • Piga M; Division of Rheumatology, Departments of Medicine, Dalhousie University and Queen Elizabeth II Health Sciences Center, B3H 4K4, Canada, Halifax, Nova Scotia.
  • Quartuccio L; Rheumatology Unit, University Clinic, AOU Cagliari, 09124, Cagliari, Italy.
  • Scirè CA; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, 09124, Italy.
  • Tomietto P; Rheumatology Unit, University of Udine, Department of Medicine, University Hospital Santa Maria della Misericordia, 33100, Udine, Italy.
  • Truglia S; Epidemiology Unit, Italian Society of Rheumatology, Milan, 20121, Italy.
  • Zanetti A; School of Medicine, University of Milano Bicocca, Milan, 20126, Italy.
  • Zen M; Internal Medicine Department, Rheumatology Unit, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), 34128, Trieste, Italy.
  • Bertsias G; Rheumatology Unit, University of Udine, Department of Medicine, University Hospital Santa Maria della Misericordia, 33100, Udine, Italy.
  • Govoni M; Epidemiology Unit, Italian Society of Rheumatology, Milan, 20121, Italy.
Article em En | MEDLINE | ID: mdl-38402539
ABSTRACT

OBJECTIVES:

The management of neuropsychiatric systemic lupus erythematosus (NPSLE) poses considerable challenges due to limited clinical trials. Therapeutic decisions are customized based on suspected pathogenic mechanisms and symptom severity. This study aimed to investigate therapeutic strategies and disease outcome for patients with NPSLE experiencing their first neuropsychiatric (NP) manifestation.

METHODS:

This retrospective cohort study defined NP events according to the American College of Rheumatology case definition, categorizing them into three clusters central/diffuse, central/focal and peripheral. Clinical judgment and a validated attribution algorithm were used for NP event attribution. Data included demographic variables, SLE disease activity index, cumulative organ damage, and NP manifestation treatments. The clinical outcome of all NP events was determined by a physician seven-point Likert scale. Predictors of clinical improvement/resolution were investigated in a multivariable logistic regression analysis.

RESULTS:

The analysis included 350 events. Immunosuppressants and corticosteroids were more frequently initiated/escalated for SLE-attributed central diffuse or focal NP manifestations. At 12 months of follow-up, 64% of patients showed a clinical improvement in NP manifestations. Focal central events and SLE-attributed manifestations correlated with higher rates of clinical improvement. Patients with NP manifestations attributed to SLE according to clinical judgment and treated with immunosuppressants had a significantly higher probability of achieving clinical response (OR 2.55, 95%CI 1.06-6.41, p= 0.04). Age at diagnosis and focal central events emerged as additional response predictors.

CONCLUSION:

NP manifestations attributed to SLE by clinical judgment and treated with immunosuppressants demonstrated improved 12-month outcomes. This underscores the importance of accurate attribution and timely diagnosis of NPSLE.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália